Abstract：Objective To analyze the value of chronic obstructive pulmonary disease patients with acute exacerbation and the serum inflammatory factor level and clinical efficacy as the goal of the combined treatment of doxophylline and mJ. Methods 74 Patients were divided into two groups according to the random table method 1：1.The control group（n=37）was treated with polytheophylline,and the observation group（n=37）was treated with polytheophylline,with therapeutic efficacy,serum inflammatory factor and lung function,and the effects of different drug treatment were analyzed. Results After treatment as the judgment time,the clinical efficacy analysis,the control group was lower than the observation group,i.e.83.78% <97.30%（P<0.05）.Before treatment as the determination time,the difference between pulmonary function index and inflammatory factor level was small（P>0.05）;after treatment as the determination time,and the observation group was better than the control group（P<0.05）. Conclusion The clinical treatment effect of doxophylline combined with methylJohnson in patients with acute exacerbations is relatively significant,which is conducive to the decline of the level of inflammatory factors,the improvement of pulmonary respiratory function,and the high clinical application value.
赵丽. 多索茶碱联合甲强龙治疗急性加重期COPD患者的疗效及对血清炎症因子水平的影响[J]. 哈尔滨医药, 2023, 43(2): 5-7.
Zhao Li. Efficacy of Doxthelline Combined with Methyl Johnson in COPD Patients with Acute Exacerbation and Its Effect on Serum Inflammatory Factor Levels. journal1, 2023, 43(2): 5-7.
2023, Vol. 43 
